Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026

Go back to Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
(NASDAQ: DNLI) Delayed: 21.37 -0.71 (3.22%)
Previous Close $22.08    52 Week High
Open $21.69    52 Week Low
Day High $21.86    P/E N/A 
Day Low $21.34    EPS
Volume 515,038